Antag Therapeutics ApS: Financial statements 2017
CVR: 38402056
Source: annual report 2017, Danish Business Authority
08/02/2017 – 31/12/2017
Antag Therapeutics ApS (CVR 38402056) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -3,717,279 and a net result of DKK -3,901,871. Equity in the 2017 report amounted to DKK 8,708,129. The solvency ratio was 86.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -3,717,279
- Profit/Loss
- DKK -3,901,871
- Equity
- DKK 8,708,129
- Total Assets
- DKK 10,086,524
- Employees
- 2
Official annual report
Keep an eye on Antag Therapeutics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of May 31, 2017, Kirsten Aarup Drejer has joined the board of directors of Antag Therapeutics ApS.
As of May 31, 2017, Anker Gunvald Lundemose has joined the board of directors of Antag Therapeutics ApS.
As of May 31, 2017, Emmanuelle Coutanceau has joined the board of directors of Antag Therapeutics ApS.
As of May 31, 2017, Jens Juul Holst has joined the board of directors of Antag Therapeutics ApS.
As of May 30, 2017, KPMG P/S has been appointed auditor of Antag Therapeutics ApS.
On May 30, 2017, the company changed its name from Antag Therapeutics IVS to Antag Therapeutics ApS.
As of February 8, 2017, Alexander Hovard Sparre-Ulrich is registered as adm. dir. of Antag Therapeutics ApS.
Antag Therapeutics ApS was founded on February 8, 2017.
About Antag Therapeutics ApS
Antag Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Antag Therapeutics IVS. The management consists of Philip Just Larsen. The board consists of Keith Richard Leonard Jr (chair), Alexander Volker Wilhelm Mayweg, Amit Kantilal Shah and Jørgen Søberg Petersen. The company's owners include Novo Holdings A/S, Dawn Holdco SCSp and Versant Venture Capital VII, L.P.. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK -191,588,449 and a net result of DKK -200,999,582 compared with DKK -32,265,249 the year before. Equity in the 2025 report amounted to DKK 235,310.